GR3004252T3 - - Google Patents

Info

Publication number
GR3004252T3
GR3004252T3 GR920400436T GR920400436T GR3004252T3 GR 3004252 T3 GR3004252 T3 GR 3004252T3 GR 920400436 T GR920400436 T GR 920400436T GR 920400436 T GR920400436 T GR 920400436T GR 3004252 T3 GR3004252 T3 GR 3004252T3
Authority
GR
Greece
Prior art keywords
methyl
abuse
susbtances
carbazol
addiction
Prior art date
Application number
GR920400436T
Other languages
Greek (el)
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3004252T3 publication Critical patent/GR3004252T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GR920400436T 1986-11-21 1992-04-02 GR3004252T3 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868627909A GB8627909D0 (en) 1986-11-21 1986-11-21 Medicaments

Publications (1)

Publication Number Publication Date
GR3004252T3 true GR3004252T3 (enExample) 1993-03-31

Family

ID=10607734

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920400436T GR3004252T3 (enExample) 1986-11-21 1992-04-02

Country Status (16)

Country Link
US (1) US4847281A (enExample)
EP (1) EP0278161B1 (enExample)
JP (1) JPH0830008B2 (enExample)
KR (1) KR950010148B1 (enExample)
AT (1) ATE74271T1 (enExample)
AU (1) AU608788B2 (enExample)
CY (1) CY1694A (enExample)
DE (1) DE3778008D1 (enExample)
DK (1) DK612787A (enExample)
ES (1) ES2033879T3 (enExample)
GB (1) GB8627909D0 (enExample)
GR (1) GR3004252T3 (enExample)
HK (1) HK36793A (enExample)
IE (1) IE61033B1 (enExample)
PH (1) PH24934A (enExample)
ZA (1) ZA878702B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5198447A (en) * 1986-11-21 1993-03-30 Glaxo Group Limited Medicaments
WO1988003801A1 (en) * 1986-11-21 1988-06-02 Glaxo Group Limited Medicaments for treatment or prevention of withdrawal syndrome
US5198459A (en) * 1987-07-11 1993-03-30 Sandoz Ltd. Use of 5HT-3 antagonists in preventing or reducing dependency on dependency-inducing agents
DE3822792C2 (de) * 1987-07-11 1997-11-27 Sandoz Ag Neue Verwendung von 5HT¶3¶-Antagonisten
US5272168A (en) * 1987-07-11 1993-12-21 Sandoz Ltd. Use of 5HT-3 antagonists in preventing or reducing dependency on dependency-inducing agents
GB8820650D0 (en) * 1988-09-01 1988-10-05 Glaxo Group Ltd Medicaments
US5292752A (en) * 1989-12-21 1994-03-08 Merrell Dow Pharmaceuticals Inc. Antithrombotic compounds
US5225407A (en) * 1990-02-22 1993-07-06 Glaxo Group Limited 5-HT3 receptor antagonists for the treatment of autism
US5397782A (en) * 1990-06-13 1995-03-14 Janssen Pharmaceutica N.V. Method of treating addiction to alcohol
CA2112487C (en) * 1991-06-26 2003-04-15 James W. Young Method and compositions for treating emesis, nausea and other disorders using optically pure r(+) ondansetron
GB9310756D0 (en) * 1993-05-25 1993-07-14 Glaxo Lab Sa Compositions
US5726644A (en) * 1995-06-30 1998-03-10 Philips Electronics North America Corporation Lighting control system with packet hopping communication
US5824684A (en) * 1997-02-21 1998-10-20 Synapse Pharmaceuticals International, Inc. Method for treating drug and alcohol addiction
US20080004260A1 (en) * 2006-06-29 2008-01-03 Transcept Pharmaceuticals, Inc. Compositions of 5-HT3 antagonists and dopamine D2 antagonists for treatment of dopamine-associated chronic conditions
CN102307895A (zh) * 2008-12-04 2012-01-04 里兰斯坦福初级大学理事会 用于治疗或预防麻醉药停药症状的方法和组合物
US20100298397A1 (en) * 2009-05-19 2010-11-25 Singh Nikhilesh N Method of treatment of obsessive compulsive disorder with ondansetron
US20110288115A1 (en) * 2010-05-24 2011-11-24 Avmedis Llc Treatment of vagally-mediated spectrum disorders
WO2021127391A1 (en) 2019-12-20 2021-06-24 The Jackson Laboratory Molecular targets for addiction
EP4673443A1 (en) * 2023-03-01 2026-01-07 The Jackson Laboratory Methods and compositions for treating cocaine addiction

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4499096A (en) * 1983-11-18 1985-02-12 Lotsof Howard S Rapid method for interrupting the narcotic addiction syndrome
HU193592B (en) * 1984-01-25 1987-11-30 Glaxo Group Ltd Process for producing tetrahydro-carbazolone derivatives
EP0385517B1 (en) * 1985-03-14 1993-04-14 BEECHAM GROUP plc Medicaments for the treatment of emesis
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
HU895334D0 (en) * 1986-07-30 1990-01-28 Sandoz Ag Process for the preparation of nasal pharmaceutical compositions
EP0272052B1 (en) * 1986-12-16 1992-07-08 A.H. ROBINS COMPANY, INCORPORATED (a Delaware corporation) Anxiolytic-N-(1-Azabicyclo[2.2.2]Oct-3-yl) Benzamides and Thobenzamides
DE3822792C2 (de) * 1987-07-11 1997-11-27 Sandoz Ag Neue Verwendung von 5HT¶3¶-Antagonisten

Also Published As

Publication number Publication date
EP0278161A1 (en) 1988-08-17
CY1694A (en) 1994-01-14
ZA878702B (en) 1988-09-28
DE3778008D1 (de) 1992-05-07
IE61033B1 (en) 1994-09-07
AU8144387A (en) 1988-05-26
DK612787D0 (da) 1987-11-20
AU608788B2 (en) 1991-04-18
ATE74271T1 (de) 1992-04-15
US4847281A (en) 1989-07-11
JPS63185927A (ja) 1988-08-01
EP0278161B1 (en) 1992-04-01
HK36793A (en) 1993-04-23
KR880005930A (ko) 1988-07-21
GB8627909D0 (en) 1986-12-31
DK612787A (da) 1988-05-22
KR950010148B1 (ko) 1995-09-11
PH24934A (en) 1990-12-26
JPH0830008B2 (ja) 1996-03-27
ES2033879T3 (es) 1995-04-01
IE873156L (en) 1988-05-21

Similar Documents

Publication Publication Date Title
GB8627909D0 (en) Medicaments
FR2720002B1 (fr) Dispositif d'incision pour l'administration dermique d'un médicament.
IL116203A (en) Pharmaceutical compositions for the treatment of emesis comprising (2s, 3s) -3-(2-methoxybenzylamino)-2-phenylpiperidine and ondansetron
EP1736147A3 (en) Non-chlorofluorocarbon aerosol formulations
IL114683A0 (en) Combination treatment for inhibiting bone loss
AU2553992A (en) Bone-growth-stimulating composition
ZA879458B (en) Medicaments
IL89788A0 (en) 2,3,4-substituted imidazoles and 3,4,5-substituted 1,2,4-triazoles,their preparation and pharmaceutical compositions containing them
IE873414L (en) Medicament for dementia
IL109376A (en) Pharmaceutical composition containing (R)-5-(methyl-aminosulfonylmethyl)-3-(N-methylpyrrolidin-2-yl-methyl)-1H-indole and (R)-5-(methylamino-sulfonylmethyl)-3-(pyrrolidin-2-ylmethyl)-1H-indole
ZA925146B (en) Pharmaceutical agent for treatment of withdrawal symptoms.
AU620218B2 (en) Anti-hiv drug
MD950171A (en) A Pharmaceutical remedy for impruving or remission - of excitement state during nervous deseases
EP0380989A3 (en) Plaster for transdermal administration
IL109866A (en) Crystalline 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine(+)L-hydrogentartrate its preparation and pharmaceutical compositions containing it
IL89571A0 (en) 3,4,5-substituted 4h-1,2,4-triazoles,their preparation and pharmaceutical compositions containing them
IE873231L (en) Medicaments
IL109749A0 (en) Pharmaceutical composition for rectal administration comprising 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1h-imidazol-1-yl)-methyl]-4h-carbazol-4-one, methods for their manufacture and their use
IL85185A0 (en) 3-aryl-5-alkylthio-4h-1,2,4-triazoles and pharmaceutical compositions containing same
IL101482A0 (en) Substituted 2',3'-dideoxy-5-trifluoromethyluridines,and pharmaceutical compositions containing them
ITTO971062A0 (it) Farmaco per la cura dell'ircismo contenente un adrenocorticosteroide.
EP0495226A3 (en) 3-aryl-5-alkylthio-4h-1,2,4-triazoles for treatment of hyperreflexia due to spinal trauma
ZA892061B (en) Antihypertensive combination
OA09750A (en) "Préparation of 6-0-acylelsamicin A derivatives".
ZA925928B (en) N-azinyl-N'-(2-ethylsulphinyl-phenylsulphonyl)-ureas.